Gonadotropin-releasing hormone analogue and recombinant human growth hormone treatment for idiopathic central precocious puberty in girls

PurposeTo investigate the effectiveness and safety of gonadotropin-releasing hormone analogue (GnRHa) in combination with recombinant human growth hormone (rhGH) in girls with central precocious puberty (CPP).MethodsClinical data of 80 girls diagnosed with idiopathic central precocious puberty (ICPP...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Yuzhen Shi, Ziyi Ma, Xi Yang, Yanqin Ying, Xiaoping Luo, Ling Hou
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2022-12-01
Serie:	Frontiers in Endocrinology
Soggetti:	central precocious puberty gonadotropin-releasing hormone analogue recombinant human growth hormone height growth velocity predicted adult height
Accesso online:	https://www.frontiersin.org/articles/10.3389/fendo.2022.1085385/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!